Target intelligence / Profile preview

Mouse double minute 4 protein (MDM4 (also known as MDMX))

Target
MDM4 (also known as MDMX)
Molecular classification
E3 ubiquitin ligase family (though lacks intrinsic E3 activity), Oncoprotein, p53 regulator
01

Overview

Mouse double minute 4 protein (MDM4, also known as Proto-oncogene protein mdmx) is a key negative regulator of the tumor suppressor p53. It shares structural similarity with its paralog Mouse double minute 2 (MDM2) but lacks intrinsic E3 ubiquitin ligase activity. Instead, it binds directly to p53, inhibiting its transcriptional activity under normal conditions. In response to DNA damage or genotoxic stress, post-translational modifications such as phosphorylation alter its function—allowing it together with MDM2—to promote stabilization and activation rather than degradation/inhibition of p53. Overexpression or amplification contributes significantly to oncogenesis by disabling one major cellular defense against malignant transformation.

Other names
Proto-oncogene protein mdmxMDMXDouble minute 4 proteinp53-binding protein Mdm4Mdm2-like p53-binding protein
02

Mechanism of action

Drugs targeting this molecule aim to inhibit the interaction between MDMX (and/or MDM2) with p53, thereby restoring or enhancing wild-type p53 function leading to cell cycle arrest or apoptosis in cancer cells with functional TP53.

03

Biological functions

Negative regulation of p53 tumor suppressor activity via direct binding and inhibition of transcriptional activationRegulation of cell cycle progression and apoptosis through modulation of p53 pathwayModulation of cellular response to DNA damage and genotoxic stress, including switching from negative to positive regulation of p53 under stress conditions
04

Disease associations

Cancer (frequently overexpressed in various human cancers, promoting tumorigenesis by inhibiting the tumor suppressor function of p53)
05

Safety considerations

Potential safety concerns include on-target toxicity due to excessive activation of wild-type p53 in normal tissues, which could lead to unwanted cell cycle arrest or apoptosis; hematologic toxicities have been observed with some dual inhibitors targeting both MDM2 and MDMX.
06

Interacting drugs

There are no approved drugs directly targeting MDMX/MDM4 in clinical use as of now. However, several experimental compounds and small molecules are being developed to disrupt the interaction between MDM2/MDMX and p53 for cancer therapy. Most clinically advanced drugs target both MDM2 and, less potently, MDMX.
07

Biomarkers

Overexpression or amplification of MDMX/MDM4 can serve as a biomarker for certain cancers where the inhibition or loss-of-function mutation in TP53 is not present but where wild-type TP53 is suppressed by high levels of its negative regulators.

Beyond the preview

Go deeper on Mouse double minute 4 protein (MDM4 (also known as MDMX)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mouse double minute 4 protein (MDM4 (also known as MDMX)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call